• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

One Medical Looks to the Chronic Care Space with Launch of New Product

Share:

October 23, 2021

One Medical, a membership-based primary care company, is stepping further into the digital chronic care space with the launch of its own product, Impact by One Medical.

The hybrid care provider’s platform includes 24/7 virtual support and integration with remote monitoring tools like Fitbit or Apple HealthKit. Patients also have access to a multidisciplinary care team that includes their primary care provider, health coaches, and care navigators as well as educational content and classes.

Impact by One Medical is available to members who clinically qualify without extra fees outside of regular co-pays and claims.

WHY IT MATTERS

The Centers for Disease Control and Prevention reports six in 10 Americans to have at least one chronic disease, like heart disease, diabetes, or cancer. Those illnesses are a large contributor to death and disability, and to healthcare costs.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

One Medical is pitching its solution as a way to address and prevent chronic conditions through its primary care offerings.

“Chronic illness is among the leading causes of death in America, with over 50% of Americans living with a chronic illness. Yet, our healthcare system has been more focused on developing point solutions like virtual-only monitoring tools and treating those that become critically ill rather than developing cohesive intervention solutions within a primary care setting,” One Medical Chief Quality Officer Dr. Raj Behal said in a statement.

“At One Medical, we’ve always recognized the importance of prevention as well as management of chronic conditions. As we will soon be in markets reaching nearly 40% of the U.S. population, we have an opportunity to continue making a real-world difference with our comprehensive approach, which can reduce the rising costs and hospitalizations caused by chronic illness.”

THE LARGER TREND

Early last month, One Medical finalized its acquisition of senior-focused provider Iora Health for about $1.4 billion. One Medical positioned its purchase as a way to combine two hybrid primary care providers who served different markets since Iora focused on the Medicare population.

This summer One Medical staffer announced plans to unionize, citing issues with wages and their workload. The company went public in early 2020 at $14 a share; One Medical stock is currently trading around $21.48 per share.

Digital chronic care management is a growing space. Telehealth giant Teladoc Health announced plans to merge with chronic-care management company Livongo in August 2020, in a deal valued at $18.5 billion. The merger was completed in October that year.

Other companies include Carbon Health, which stepped into digital chronic-care management with the acquisition of the diabetes-care platform Steady Health, Omada Health, Sweetch, and Lark Health.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • MED Healthcare’s $28.5M Portfolio Pickup; 444-Bed Lease in St. LouisMED Healthcare’s $28.5M Portfolio Pickup; 444-Bed Lease in St. Louis
  • Eurofins Discovery Announces Acquisition of DiscoveryBioMedEurofins Discovery Announces Acquisition of DiscoveryBioMed
  • Call to Action: Restrictions Around Virtual Health Can’t Go Back to “Normal”Call to Action: Restrictions Around Virtual Health Can’t Go Back to “Normal”
  • Debiopharm and ThinkingNodeLife.ai Partner on AI-driven Cancer Drug DevelopmentDebiopharm and ThinkingNodeLife.ai Partner on AI-driven Cancer Drug Development
  • Cybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic TherapeuticsCybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics
  • Concentra, the Nation’s Leading Provider of Occupational Health, Selects the eVisit Virtual Care PlatformConcentra, the Nation’s Leading Provider of Occupational Health, Selects the eVisit Virtual Care Platform
  • H.I.G. Capital Completes Acquisition of Jenny CraigH.I.G. Capital Completes Acquisition of Jenny Craig
  • symplr Completes Acquisition of Halo Healthsymplr Completes Acquisition of Halo Health

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications